<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05024669</url>
  </required_header>
  <id_info>
    <org_study_id>Harisha</org_study_id>
    <nct_id>NCT05024669</nct_id>
  </id_info>
  <brief_title>Efficacy of Desensitizers in Reducing Post-operative Sensitivity Following Composite Restorations</brief_title>
  <official_title>Efficacy of Three Commercially Available Desensitizers in Reducing Post-operative Sensitivity Following Composite Restorations: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jazan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jazan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Composite is one of the common aesthetic restorations used in the dentistry. With the&#xD;
      advancements in the biomaterials the application of the composites has broadened. However due&#xD;
      to various factors the composites are associated with dental sensitivity. Hence in our study&#xD;
      we evaluate and compare the effectiveness of three desensitizing agents in reducing the&#xD;
      post-treatment sensitivity for class I composite restoration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double-blind, randomized, controlled clinical trial was conducted in which 80 subjects&#xD;
      requiring class I cavity were randomly assigned to 4 groups of 20 patients each: Group C&#xD;
      (Control group), Group GL (Gluma group), Group SF (Shield Force Plus group), and Group TC&#xD;
      (Telio CS group). The class 1 cavity was prepared and after etching, the desensitizers were&#xD;
      applied (except in the control group) and later composite restoration was done. The&#xD;
      postoperative pain/sensitivity level was recorded according to the Visual Analogue Scale&#xD;
      (VAS) on intake of cold drinks; intake of hot drinks; and intake of sugar for different&#xD;
      periods of time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2020</start_date>
  <completion_date type="Actual">May 10, 2021</completion_date>
  <primary_completion_date type="Actual">April 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of application of the desensitisers on post operative sensitivity on the day of composite restoration on application of different stimuli like (i) Intake of cold drinks; (ii) Intake of hot drinks; and (iii) Intake of sugar.</measure>
    <time_frame>Within 24 hours</time_frame>
    <description>The patients were given a questionnaire and instructed to record any postoperative pain/sensitivity level according to the Visual Analogue Scale (VAS) for restored tooth on the day of restoration on taking cold drinks, hot drinks, and sugar.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of application of the desensitisers on post operative sensitivity one week after the composite restoration on application of different stimuli like (i) Intake of cold drinks; (ii) Intake of hot drinks; and (iii) Intake of sugar.</measure>
    <time_frame>After one week</time_frame>
    <description>The patients were given a questionnaire and instructed to record any postoperative pain/sensitivity level according to the Visual Analogue Scale (VAS) for restored tooth one week after the restoration on taking cold drinks, hot drinks, and sugar.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of application of the desensitisers on post operative sensitivity one month after the composite restoration on application of different stimuli like (i) Intake of cold drinks; (ii) Intake of hot drinks; and (iii) Intake of sugar.</measure>
    <time_frame>after one month</time_frame>
    <description>The patients were given a questionnaire and instructed to record any postoperative pain/sensitivity level according to the Visual Analogue Scale (VAS) for restored tooth one month after the restoration on taking cold drinks, hot drinks, and sugar.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Sensitivity</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>where no desensitizer application was done,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group GL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>applied with Gluma dentin desensitizer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group SF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>applied with Shieldforce desensitizer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group TC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>applied with Telio CS desensitizer</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Gluma desensitiser</intervention_name>
    <description>Gluma desensitiser was used before restoration.</description>
    <arm_group_label>Group GL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Sheildforce Plus desensitiser</intervention_name>
    <description>Sheildforce Plus desensitiser was used before restoration.</description>
    <arm_group_label>Group SF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Telio CS desensitiser</intervention_name>
    <description>Telio CS desensitiser was used before restoration.</description>
    <arm_group_label>Group TC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The selection criteria:&#xD;
&#xD;
          -  Age was 20-45 years.&#xD;
&#xD;
          -  Vital teeth, (electric pulp test)&#xD;
&#xD;
          -  Apical periodontal ligament space radiographically identified&#xD;
&#xD;
          -  The remaining dentin thickness at least 1mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Restored, periodontally weak nonvital teeth are excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harisha Dewan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jazan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harisha Dewan</name>
      <address>
        <city>Jazan</city>
        <zip>45142</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 14, 2021</study_first_submitted>
  <study_first_submitted_qc>August 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>August 22, 2021</last_update_submitted>
  <last_update_submitted_qc>August 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jazan</investigator_affiliation>
    <investigator_full_name>Dr Harisha Dewan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Gluma</keyword>
  <keyword>Sheildforce Plus</keyword>
  <keyword>Telio CS</keyword>
  <keyword>Desensitisers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

